Organic Flower Dives Into Psychedelics Investments, Hires New Talent

Pharmaceutical company Organic Flower Investments Group SOW QILFF has formed a special committee to analyze profitable investments in the psychedelics space.

This is part of an R&D effort for medicine and biotech.

The committee will focus on analyzing potential investments in these fields and initiating a series of investigations to reach results that generate a positive return on capital.

Among the expected investigations are the search for new drugs, pre-clinical studies and clinical trials, and the development of platforms for the analysis and data collection of the effect of psychedelics on the body.

In addition to this announcement, it was also affirmed that Joel Dumaresq resigned as director of OFIG, maintaining its position as CEO and interim CFO of Organic Flower Investment Group.

The company appointed Joe Perino, former professor Coordinator of the Police Foundations Program, as his replacement.

Perino has 40 years of experience with the Toronto Police Service.

Market News and Data brought to you by Benzinga APIs
Posted In: CannabisPenny StocksHealth CareSmall BusinessMarketsGeneralorganic flowerPsychedelics
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

The Benzinga Cannabis Capital Conference is coming to Florida

The Benzinga Cannabis Capital Conference is returning to Florida, in a new venue in Hollywood, on April 16 and 17, 2024. The two-day event at The Diplomat Beach Resort will be a chance for entrepreneurs, both large and small, to network, learn and grow. Renowned for its trendsetting abilities and influence on the future of cannabis, mark your calendars – this conference is the go-to event of the year for the cannabis world.

Get your tickets now on bzcannabis.com – Prices will increase very soon!


Loading...